Heroin Use Disorder
📧 Sign up to get email alerts when something new happens for Heroin Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Neurofeedback During Naturalistic Stimuli to Reduce Craving in Heroin Addiction [NA]
A completed clinical trial evaluated neurofeedback during naturalistic stimuli to reduce cravings in individuals with heroin use disorder an…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Neuroimaging and CBD for Opioid Use Disorder [Phase 2]
Phase 2 clinical trial evaluating neuroimaging biomarkers and cannabidiol for opioid use disorder (heroin use disorder) has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 [Phase 2]
A Phase 2 trial update evaluating the efficacy of methadyl acetate (LAAM) in combination with contingency management for treating dual opioi…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Memantine as a Supplement to Naltrexone in Treating Heroin Dependence [Phase 2, Phase 3]
Memantine was studied as a supplement to naltrexone for heroin/opioid dependence. The trial completed Phase 2 and Phase 3 with results poste…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
This clinical trial update reports the completion of a study evaluating SR-Amphetamine plus buprenorphine to reduce cocaine and heroin use. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals.
A completed clinical trial examining how environmental factors influence opiate drug choice in individuals with opioid use disorders.
-
CLINICAL_TRIALS trial_result · 2008-08-01Clinical Trial Update: Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers [Phase 1]
Phase 1 study exploring whether the NK1 receptor antagonist aprepitant can block opioid reward in non-dependent opiate abusers.